PMID

Data

Article Title

Organization

Sulfonamide inhibition studies of twoß-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.

Kochi Medical School

Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition.

Kochi Medical School

Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.

Kochi Medical School

Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.

Kochi Medical School

Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.

Kochi Medical School

Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.

Kochi Medical School

Inhibition studies of theß-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.

Kochi Medical School

Anion inhibition studies of two new β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.

Kochi Medical School

Pharmaceutically active pyrazine derivatives

Sentinel Oncology

Benzenesulfonamide compounds and their use as therapeutic agents

Xenon Pharmaceuticals

Pyridine compounds

Daiichi Sankyo

Pyrrolopyrrolone derivatives and their use as BET inhibitors

Novartis